Suyu Dong

Prof. Dr. Suyu Dong


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2017 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
GLGongning Luo
Gongning Luo
SDSuyu Dong
Suyu Dong
KWKuanquan Wang
Kuanquan Wang
WZWangmeng Zuo
Wangmeng Zuo
SCShaodong Cao
Shaodong Cao
HZHenggui Zhang
Henggui Zhang
Objective: Left ventricular (LV) volumes estimation is a critical procedure for cardiac disease diagnosis. The objective of this paper is to address direct LV volumes prediction task. Methods: In this paper, we propose a direct volumes prediction method based on the end-to-end deep convolutional neural networks (CNN). We study the end-to-end LV volumes prediction method in items of the data preprocessing, networks structure, and multi-views fusion strategy. The main contributions of this paper are the following aspects. First, we propose a new data preprocessing method on cardiac magnetic resonance (CMR). Second, we propose a new networks structure for end-to-end LV volumes estimation. Third, we explore the representational capacity of different slices, and propose a fusion strategy to improve the prediction accuracy. Results: The evaluation results show that the proposed method outperforms other state-of-the-art LV volumes estimation methods on the open accessible benchmark datasets. The clinical indexes derived from the predicted volumes agree well with the ground truth (EDV: R$^2$=0.974, RMSE=9.6ml; ESV: R$^2$=0.976, RMSE=7.1ml; EF: R$^2$=0.828, RMSE =4.71%). Conclusion: Experimental results prove that the proposed method has high accuracy and efficiency on LV volumes prediction task. Significance: The proposed method not only has application potential for cardiac diseases screening for large-scale CMR data, but also can be extended to other medical image research fields.

4 October 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
Jieyun BaiJieyun Bai
Jieyun Bai
KWKuanquan Wang
Kuanquan Wang
YLYashu Liu
Yashu Liu
YLYacong Li
Yacong Li
CLCuiping Liang
Cuiping Liang
HZHenggui Zhang
Henggui Zhang
Functional analysis of the L-type calcium channel has shown that the CACNA1C R858H mutation associated with severe QT interval prolongation may lead to ventricular fibrillation (VF). This study investigated multiple potential mechanisms by which the CACNA1C R858H mutation facilitates and perpetuates VF. The Ten Tusscher-Panfilov (TP06) human ventricular cell models incorporating the experimental data on the kinetic properties of L-type calcium channels were integrated into one-dimensional (1D) fiber, 2D sheet, and 3D ventricular models to investigate the pro-arrhythmic effects of CACNA1C mutations by quantifying changes in intracellular calcium handling, action potential profiles, action potential duration restitution (APDR) curves, dispersion of repolarization (DOR), QT interval and spiral wave dynamics. R858H “mutant” L-type calcium current (ICaL) augmented sarcoplasmic reticulum calcium content, leading to the development of afterdepolarizations at the single cell level and focal activities at the tissue level. It also produced inhomogeneous APD prolongation, causing QT prolongation and repolarization dispersion amplification, rendering R858H “mutant” tissue more vulnerable to the induction of reentry compared with other conditions. In conclusion, altered ICaL due to the CACNA1C R858H mutation increases arrhythmia risk due to afterdepolarizations and increased tissue vulnerability to unidirectional conduction block. However, the observed reentry is not due to afterdepolarizations (not present in our model), but rather to a novel blocking mechanism.

27 March 2026 in Nature Computational Science
Verified
Journal Article
Closed access
YCYuetan Chu
Yuetan Chu
LZLongxi Zhou
Longxi Zhou
GLGongning Luo
Gongning Luo
KKKai Kang
Kai Kang
SDSuyu Dong
Suyu Dong
XGXin Gao
Xin Gao

23 May 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
QYQiang Yang
Qiang Yang
LXLong Xu
Long Xu
WDWeihe Dong
Weihe Dong
XLXiaokun Li
Xiaokun Li
KWKuanquan Wang
Kuanquan Wang
GWGuo-Hua Wang
Guo-Hua Wang
While significant strides have been made in predicting neoepitopes that trigger autologous CD4+ T cell responses, accurately identifying the antigen presentation by human leukocyte antigen (HLA) class II molecules remains a challenge. This identification is critical for developing vaccines and cancer immunotherapies. Current prediction methods are limited, primarily due to a lack of high-quality training epitope datasets and algorithmic constraints. To predict the exogenous HLA class II-restricted peptides across most of the human population, we utilized the mass spectrometry data to profile >223 000 eluted ligands over HLA-DR, -DQ, and -DP alleles. Here, by integrating these data with peptide processing and gene expression, we introduce HLAIImaster, an attention-based deep learning framework with adaptive domain knowledge for predicting neoepitope immunogenicity. Leveraging diverse biological characteristics and our enhanced deep learning framework, HLAIImaster is significantly improved against existing tools in terms of positive predictive value across various neoantigen studies. Robust domain knowledge learning accurately identifies neoepitope immunogenicity, bridging the gap between neoantigen biology and the clinical setting and paving the way for future neoantigen-based therapies to provide greater clinical benefit. In summary, we present a comprehensive exploitation of the immunogenic neoepitope repertoire of cancers, facilitating the effective development of “just-in-time” personalized vaccines.

1 November 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
XLXiaokun Li
Xiaokun Li
QYQiang Yang
Qiang Yang
LXLong Xu
Long Xu
WDWeihe Dong
Weihe Dong
KWKuanquan Wang
Kuanquan Wang
GWGuo-Hua Wang
Guo-Hua Wang
T-cell receptors (TCR), which are heterodimers of $\alpha $ and $\beta $ chains that recognize foreign antigens, are of great significance to current immunotherapy. Although artificial intelligence (AI) has explosively accelerated de novo protein design, the challenge of therapeutic TCR design has been overlooked by most researchers. Existing TCR engineering relies heavily on isolating antigen-specific TCRs from tumor tissues, which requires a large amount of labor resources and wet experimental verification. To mitigate this issue, we present TCRdesign, a pretrained generative protein language model (PLM) for the de novo design of artificial TCR $\beta $-chain complementarity-determining region 3 sequences conditioned on antigen-binding specificity (BS). In parallel, we develop a high-accuracy binding predictor (TCRBinder) that couples paired $\alpha $/$\beta $ chain information with antigen sequences to assess BS. Our in silico comparisons demonstrate that (i) TCRdesign surpasses state-of-the-art baselines in generating antigen-specific TCR sequences. The model leverages paired-chain coherence to refine amino-acid level interaction patterns. (ii) TCRdesign-generated TCR sequences exhibit better antigen binding capability to diverse oncogenic hotspots compared with natural counterparts. (iii) TCRdesign inherits the intrinsic properties of large PLMs, enabling effectively identify the determinant residues in TCR-antigen binding, which enhances its interpretability. These results highlight the significant capability of TCRdesign in understanding and generating TCR sequences with an antigen-specific interaction pattern, charting a versatile path toward AI-driven T-cell engineering for precision immunotherapy.

29 March 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XLXiaokun Li
Xiaokun Li
QYQiang Yang
Qiang Yang
LXLong Xu
Long Xu
WDWeihe Dong
Weihe Dong
GLGongning Luo
Gongning Luo
XGXin Gao
Xin Gao
Motivation: Understanding the intermolecular interactions of ligand–target pairs is key to guiding the optimization of drug research on cancers, which can greatly mitigate overburden workloads for wet labs. Several improved computational methods have been introduced and exhibit promising performance for these identification tasks, but some pitfalls restrict their practical applications: (i) first, existing methods do not sufficiently consider how multigranular molecule representations influence interaction patterns between proteins and compounds; and (ii) second, existing methods seldom explicitly model the binding sites when an interaction occurs to enable better prediction and interpretation, which may lead to unexpected obstacles to biological researchers. Results: To address these issues, we here present DrugMGR, a deep multigranular drug representation model capable of predicting binding affinities and regions for each ligand–target pair. We conduct consistent experiments on three benchmark datasets using existing methods and introduce a new specific dataset to better validate the prediction of binding sites. For practical application, target-specific compound identification tasks are also carried out to validate the capability of real-world compound screen. Moreover, the visualization of some practical interaction scenarios provides interpretable insights from the results of the predictions. The proposed DrugMGR achieves excellent overall performance in these datasets, exhibiting its advantages and merits against state-of-the-art methods. Thus, the downstream task of DrugMGR can be fine-tuned for identifying the potential compounds that target proteins for clinical treatment. Availability and implementation: https://github.com/lixiaokun2020/DrugMGR.